Rheumatoid Arthritis Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02405780A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis PatientsTreatment
NCT02260791A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis PatientsTreatment
NCT02019472A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisTreatment
NCT00660647Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)Treatment
NCT01970475Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid ArthritisTreatment
NCT02889796Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateTreatment
NCT02480153A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).Treatment
NCT02744755Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid ArthritisTreatment
NCT02722044Usability of an AI for M923 in Subjects With Moderate to Severe RATreatment
NCT00049751Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid ArthritisTreatment
NCT00234936Quality of Life Study With Adalimumab in Rheumatoid ArthritisTreatment
NCT01231321A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid ArthritisTreatment
NCT00235872Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisTreatment
NCT00235859Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateTreatment
NCT00233571A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid ArthritisTreatment
NCT00234845Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisTreatment
NCT00195650Long Term Open Label Continuation StudyTreatment
NCT00195702Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.Treatment
NCT02167139A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyTreatment
NCT00870467A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisTreatment
NCT00647920Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With MethotrexateTreatment
NCT00647270Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week DosingTreatment
NCT00853385A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisTreatment
NCT00448383A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid ArthritisTreatment
NCT00929864Abatacept Versus Adalimumab Head-to-HeadTreatment
NCT01710358A Study in Moderate to Severe Rheumatoid ArthritisTreatment
NCT00603993Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisTreatment